KIMS Subsidiary Receives ₹12.42 Crore GST Demand Order
KIMS subsidiary, Spanv Medisearch Lifesciences Private Limited, received a GST demand order for ₹12.42 crore. The order, dated December 31, 2025, is for FY 2021-22 and requires payment by March 30, 2026. KIMS is consulting legal advisors to explore appeal options.
The demand order of ₹12.42 crore could impact the subsidiary's financials if not resolved, but the company is exploring legal options, which may mitigate the impact.
The company's subsidiary has received a significant demand order from the GST department, which is a negative development.
Krishna Institute of Medical Sciences Limited (KIMS) announced that its subsidiary, Spanv Medisearch Lifesciences Private Limited, has received a demand order from the Office of the Deputy Commissioner of State Tax (GST) Nagpur.
The demand order, dated 31st December 2025, is for ₹12.42 crores and pertains to the financial year 2021-22. The order is based on the alleged non-payment of GST on medicines consumed for inpatients.
The subsidiary has been directed to settle the dues by 30th March 2026. KIMS stated that it is examining the matter with its legal and tax advisors and will take appropriate steps as per applicable laws. The company is exploring all legal options, including filing an appeal.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.